Vivos Therapeutics (VVOS) Other Non-Current Assets (2019 - 2026)
Vivos Therapeutics (VVOS) posted quarterly Other Non-Current Assets of $254000.0 for Q1 2026, up 18.14% year-over-year from $215000.0 in Q1 2025, and up 11.4% quarter-over-quarter from $228000.0 in Q4 2025.
Vivos Therapeutics (VVOS) Other Non-Current Assets (2019 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has reported Other Non-Current Assets for 8 consecutive years, with $254000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non-Current Assets rose 18.14% year-over-year to $254000.0; the TTM figure through Mar 2026 stood at $254000.0 (up 18.14% YoY), while the FY2025 annual figure was $228000.0, up 5.56% from the prior year.
- Other Non-Current Assets grew to $254000.0 in Q1 2026 per VVOS's latest filing, from $228000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $374000.0 in Q4 2022 and bottomed at $211000.0 in Q3 2025.
- Historically, Other Non-Current Assets has averaged $290705.9 across 5 years, with a median of $307000.0 in 2023.
- Annual changes were most pronounced in 2025 — Other Non-Current Assets tumbled 30.19% — and 2026, when it climbed 18.14%.
- Vivos Therapeutics' Other Non-Current Assets stood at $374000.0 in 2022, then slipped by 17.91% to $307000.0 in 2023, then dropped by 29.64% to $216000.0 in 2024, then rose by 5.56% to $228000.0 in 2025, then climbed by 11.4% to $254000.0 in 2026.
- Business Quant data shows VVOS's Other Non-Current Assets at $254000.0 in Q1 2026, $228000.0 in Q4 2025, and $211000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 3.23 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 616.40 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 273.70 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 148.78 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 215.10 Mn |
| 10 | Vivos Therapeutics | 5.18 Mn | 3.38 Mn | 2.95 Mn | 272,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 254,000.00 |
| Dec 31, 2025 | 228,000.00 |
| Sep 30, 2025 | 211,000.00 |
| Jun 30, 2025 | 255,000.00 |
| Mar 31, 2025 | 215,000.00 |
| Dec 31, 2024 | 216,000.00 |
| Sep 30, 2024 | 276,000.00 |
| Jun 30, 2024 | 276,000.00 |
| Mar 31, 2024 | 308,000.00 |
| Dec 31, 2023 | 307,000.00 |
| Sep 30, 2023 | 307,000.00 |
| Jun 30, 2023 | 308,000.00 |
| Mar 31, 2023 | 308,000.00 |
| Dec 31, 2022 | 374,000.00 |
| Sep 30, 2022 | 372,000.00 |
| Jun 30, 2022 | 373,000.00 |
| Mar 31, 2022 | 354,000.00 |
| Dec 31, 2021 | 356,000.00 |
| Sep 30, 2021 | 355,698.00 |
| Jun 30, 2021 | 374,648.00 |